IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Matrix Capital Management Company, LP

Q3 2024 Holdings

Filed 2024-11-14 | 7 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Altair Engr Inc(ALTREUR)COM CL A021369103$1.2B12,430,00056.7%
Globalfoundries Inc(GFS)ORDINARY SHARESG39387108$664.7M16,514,95231.7%
Perimeter Solutions SA(PRM)COMMON STOCKL7579L106$90.5M6,725,0004.3%
Aura Biosciences Inc(AURA)COM05153U107$61.7M6,922,8702.9%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$51.4M13,959,9732.5%
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$35.8M37,681,5151.7%
Adaptive Biotechnologies COR(ADPT)COM00650F109$3.3M650,0000.2%